Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)

Peer Review reports

Original Submission
25 Mar 2021	Submitted	Original manuscript
23 Apr 2021	Reviewed	Reviewer Report
10 May 2021	Reviewed	Reviewer Report
25 May 2021	Author responded	Author comments - Jennifer Pascoe
Resubmission - Version 2
25 May 2021	Submitted	Manuscript version 2
13 Jun 2021	Author responded	Author comments - Jennifer Pascoe
Resubmission - Version 3
13 Jun 2021	Submitted	Manuscript version 3
Publishing
17 Jun 2021	Editorially accepted
12 Jul 2021	Article published	10.1186/s12885-021-08519-8

Back to article page